Cerebrospinal fluid kinetics of urolithin A study
Summary
NIH/NLM published a clinical trial registration on ClinicalTrials.gov (NCT07517913) for a study examining the cerebrospinal fluid pharmacokinetics of urolithin A in approximately 12 healthy participants. The single-center, open-label study will assess how urolithin A distributes into cerebrospinal fluid following oral administration.
What changed
NIH/NLM registered a new clinical trial on ClinicalTrials.gov (NCT07517913) titled "Cerebrospinal fluid kinetics of urolithin A study." The trial will evaluate the pharmacokinetics of urolithin A in cerebrospinal fluid following oral administration in healthy adult participants. The single-center, open-label study plans to enroll approximately 12 subjects and is sponsored by Amazentis SA.
Healthcare researchers and supplement manufacturers monitoring urolithin A-related research should track this trial for data on whether orally administered urolithin A achieves measurable concentrations in cerebrospinal fluid, which would support further investigation into neurological applications of the compound.
What to do next
- Monitor for study completion and results posting on ClinicalTrials.gov
- Review results when published to assess implications for urolithin A supplement development
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH/NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.